Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.

Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, Weintraub ES, Belongia EA.

Vaccine. 2019 Oct 16;37(44):6673-6681. doi: 10.1016/j.vaccine.2019.09.035. Epub 2019 Sep 17.

2.

Efficacy of a Web-Based Intervention to Increase Uptake of Maternal Vaccines: An RCT.

O'Leary ST, Narwaney KJ, Wagner NM, Kraus CR, Omer SB, Glanz JM.

Am J Prev Med. 2019 Oct;57(4):e125-e133. doi: 10.1016/j.amepre.2019.05.018. Epub 2019 Aug 27.

PMID:
31471001
3.

A primer on quantitative bias analysis with positive predictive values in research using electronic health data.

Newcomer SR, Xu S, Kulldorff M, Daley MF, Fireman B, Glanz JM.

J Am Med Inform Assoc. 2019 Dec 1;26(12):1664-1674. doi: 10.1093/jamia/ocz094.

PMID:
31365086
4.

'Reducing Delays In Vaccination' (REDIVAC) trial: a protocol for a randomised controlled trial of a web-based, individually tailored, educational intervention to improve timeliness of infant vaccination.

Dempsey AF, Wagner N, Narwaney K, Pyrzanowski J, Kwan BM, Kraus C, Gleason K, Resnicow K, Sevick C, Cataldi J, Brewer SE, Glanz JM.

BMJ Open. 2019 May 22;9(5):e027968. doi: 10.1136/bmjopen-2018-027968.

5.

Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy.

Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S.

JAMA Netw Open. 2019 Apr 5;2(4):e192613. doi: 10.1001/jamanetworkopen.2019.2613.

6.

Development and evaluation of a standardized research definition for opioid overdose outcomes.

Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM.

Subst Abus. 2019;40(1):71-79. doi: 10.1080/08897077.2018.1546263. Epub 2019 Mar 15.

PMID:
30875477
7.

Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule.

Xu S, Newcomer SR, Kulldorff M, Daley MF, Fireman B, Glanz JM.

Vaccine. 2019 Feb 28;37(10):1325-1331. doi: 10.1016/j.vaccine.2019.01.040. Epub 2019 Jan 29.

PMID:
30709727
8.

Social Media Vaccine Websites: A Comparative Analysis of Public and Moderated Websites.

Shoup JA, Narwaney KJ, Wagner NM, Kraus CR, Gleason KS, Albright K, Glanz JM.

Health Educ Behav. 2019 Jun;46(3):454-462. doi: 10.1177/1090198118818253. Epub 2018 Dec 29.

PMID:
30596265
9.

Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care.

Binswanger IA, Joseph N, Hanratty R, Gardner EM, Durfee J, Narwaney KJ, Breslin K, Mueller SR, Glanz JM.

Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 2;2(4):309-316. doi: 10.1016/j.mayocpiqo.2018.09.005. eCollection 2018 Dec.

10.

Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.

McClure DL, Jacobsen SJ, Klein NP, Naleway AL, Kharbanda EO, Glanz JM, Jackson LA, Weintraub ES, McLean HQ.

Vaccine. 2019 Jan 3;37(1):76-79. doi: 10.1016/j.vaccine.2018.11.038. Epub 2018 Nov 23.

11.

Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone.

Binswanger IA, Glanz JM.

Drug Saf. 2018 Oct;41(10):979-980. doi: 10.1007/s40264-018-0705-8. No abstract available.

12.

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.

Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA.

Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):921-925. doi: 10.1002/pds.4569. Epub 2018 Jun 3.

13.

Addressing Parents' Vaccine Concerns: A Randomized Trial of a Social Media Intervention.

Daley MF, Narwaney KJ, Shoup JA, Wagner NM, Glanz JM.

Am J Prev Med. 2018 Jul;55(1):44-54. doi: 10.1016/j.amepre.2018.04.010. Epub 2018 May 14.

PMID:
29773490
14.

Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.

Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM.

Biom J. 2018 Jul;60(4):748-760. doi: 10.1002/bimj.201700088. Epub 2018 May 16.

15.

Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM.

Acad Pediatr. 2018 Sep - Oct;18(7):754-762. doi: 10.1016/j.acap.2018.03.007. Epub 2018 Mar 28.

16.

Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age.

Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O.

JAMA. 2018 Mar 6;319(9):906-913. doi: 10.1001/jama.2018.0708.

17.

Infant Hospitalizations and Mortality After Maternal Vaccination.

Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES.

Pediatrics. 2018 Mar;141(3). pii: e20173310. doi: 10.1542/peds.2017-3310. Epub 2018 Feb 20.

18.

Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines.

Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):405-412. doi: 10.1002/pds.4399. Epub 2018 Feb 13.

19.

Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy.

Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA.

J Gen Intern Med. 2018 Oct;33(10):1646-1653. doi: 10.1007/s11606-017-4288-3. Epub 2018 Jan 29.

20.

Bias from outcome misclassification in immunization schedule safety research.

Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):221-228. doi: 10.1002/pds.4374. Epub 2018 Jan 2.

21.

Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.

Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, Jacobsen SJ, Weintraub ES, Klein NP, Gargiullo PM, Fry AM.

BMC Pulm Med. 2017 Dec 16;17(1):208. doi: 10.1186/s12890-017-0552-x.

22.

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.

Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E.

Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):59-68. doi: 10.1002/pds.4349. Epub 2017 Nov 17.

23.

Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial.

Glanz JM, Wagner NM, Narwaney KJ, Kraus CR, Shoup JA, Xu S, O'Leary ST, Omer SB, Gleason KS, Daley MF.

Pediatrics. 2017 Dec;140(6). pii: e20171117. doi: 10.1542/peds.2017-1117. Epub 2017 Nov 6.

24.

Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations.

Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK.

Influenza Other Respir Viruses. 2018 Jan;12(1):122-131. doi: 10.1111/irv.12495. Epub 2018 Feb 15.

25.

Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA.

Vaccine. 2017 Sep 25;35(40):5314-5322. doi: 10.1016/j.vaccine.2017.06.069.

26.

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.

Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA.

Vaccine. 2017 Oct 13;35(43):5872-5877. doi: 10.1016/j.vaccine.2017.08.086. Epub 2017 Sep 6.

27.

Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM.

Vaccine. 2017 Apr 4;35(15):1873-1878. doi: 10.1016/j.vaccine.2017.02.058. Epub 2017 Mar 9.

28.

Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.

Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA.

J Gen Intern Med. 2017 Mar;32(3):277-283. doi: 10.1007/s11606-016-3895-8. Epub 2016 Oct 31.

29.

White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.

Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF.

Vaccine. 2016 Feb 15;34 Suppl 1:A1-A29. doi: 10.1016/j.vaccine.2015.10.082.

PMID:
26830300
30.

Vaccine hesitancy: Causes, consequences, and a call to action.

Salmon DA, Dudley MZ, Glanz JM, Omer SB.

Vaccine. 2015 Nov 27;33 Suppl 4:D66-71. doi: 10.1016/j.vaccine.2015.09.035.

PMID:
26615171
31.

Influenza Vaccination During Pregnancy: Influenza Seasons 2002-2012, Vaccine Safety Datalink.

Groom HC, Henninger ML, Smith N, Koppolu P, Cheetham TC, Glanz JM, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, McCarthy NL, Nordin JD, Weintraub ES, Naleway AL.

Am J Prev Med. 2016 Apr;50(4):480-488. doi: 10.1016/j.amepre.2015.08.017. Epub 2015 Oct 31.

PMID:
26526159
32.

Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.

Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F.

Vaccine. 2015 Nov 27;33(48):6736-44. doi: 10.1016/j.vaccine.2015.10.076. Epub 2015 Oct 27.

PMID:
26518400
33.

Vaccine Hesitancy: Causes, Consequences, and a Call to Action.

Salmon DA, Dudley MZ, Glanz JM, Omer SB.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S391-8. doi: 10.1016/j.amepre.2015.06.009. Epub 2015 Aug 31.

PMID:
26337116
34.

Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing.

Glanz JM, Kraus CR, Daley MF.

PLoS Biol. 2015 Aug 7;13(8):e1002227. doi: 10.1371/journal.pbio.1002227. eCollection 2015 Aug.

35.

Immunization Coverage Among Juvenile Justice Detainees.

Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A.

J Correct Health Care. 2015 Jul;21(3):265-75. doi: 10.1177/0885066615587790.

PMID:
26084948
36.

Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM.

J Gen Intern Med. 2015 Dec;30(12):1837-44. doi: 10.1007/s11606-015-3394-3.

37.

A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA.

Subst Abus. 2015;36(2):240-53. doi: 10.1080/08897077.2015.1010032. Epub 2015 Mar 16. Review.

38.

Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice.

Binswanger IA, Glanz JM.

Subst Abus. 2015;36(2):141-3. doi: 10.1080/08897077.2014.991058. Epub 2015 Feb 11.

39.

Development of an interactive social media tool for parents with concerns about vaccines.

Shoup JA, Wagner NM, Kraus CR, Narwaney KJ, Goddard KS, Glanz JM.

Health Educ Behav. 2015 Jun;42(3):302-12. doi: 10.1177/1090198114557129. Epub 2014 Nov 19.

PMID:
25413375
40.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F.

Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Review.

41.

Timely versus delayed early childhood vaccination and seizures.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F.

Pediatrics. 2014 Jun;133(6):e1492-9. doi: 10.1542/peds.2013-3429.

PMID:
24843064
42.

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.

Vaccine. 2014 May 23;32(25):3019-24. doi: 10.1016/j.vaccine.2014.03.063. Epub 2014 Mar 31.

PMID:
24699471
43.

Vaccinations given during pregnancy, 2002-2009: a descriptive study.

Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C, Glanz JM, Hambidge SJ, Davis RL, Klein NP, McCarthy NL, Weintraub E.

Am J Prev Med. 2014 Feb;46(2):150-7. doi: 10.1016/j.amepre.2013.10.010.

PMID:
24439348
44.

Risk of intussusception after monovalent rotavirus vaccination.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, DeStefano F.

N Engl J Med. 2014 Feb 6;370(6):513-9. doi: 10.1056/NEJMoa1311738. Epub 2014 Jan 14.

45.

Mini-Sentinel methods: framework for assessment of positive results from signal refinement.

McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):3-8. doi: 10.1002/pds.3547. Epub 2013 Nov 25. No abstract available.

PMID:
24395545
46.

Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.

Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, Xu S.

Am J Epidemiol. 2013 Dec 15;178(12):1750-9. doi: 10.1093/aje/kwt211. Epub 2013 Sep 27.

PMID:
24327463
47.

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.

Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES.

JAMA Pediatr. 2013 Nov;167(11):1060-4. doi: 10.1001/jamapediatrics.2013.2353.

PMID:
24019039
48.

A mixed methods study of parental vaccine decision making and parent-provider trust.

Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley MF.

Acad Pediatr. 2013 Sep-Oct;13(5):481-8. doi: 10.1016/j.acap.2013.05.030.

49.

Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children.

Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM.

Vaccine. 2013 Aug 20;31(37):3894-8. doi: 10.1016/j.vaccine.2013.06.051. Epub 2013 Jul 2.

PMID:
23831326
50.

Patterns of care and persistence after incident elevated blood pressure.

Daley MF, Sinaiko AR, Reifler LM, Tavel HM, Glanz JM, Margolis KL, Parker E, Trower NK, Chandra M, Sherwood NE, Adams K, Kharbanda EO, Greenspan LC, Lo JC, O'Connor PJ, Magid DJ.

Pediatrics. 2013 Aug;132(2):e349-55. doi: 10.1542/peds.2012-2437. Epub 2013 Jul 1.

Supplemental Content

Loading ...
Support Center